Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hilde Lysvand

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Viruses|August 28, 2021
Active Components of Commonly Prescribed Medicines Affect Influenza A Virus-Host Cell Interaction: A Pilot StudyAleksandr Ianevski, Rouan Yao, Eva Zusinaite, et al.
Journal of the Pediatric Infectious Diseases Society|April 26, 2021
Parechovirus A in Hospitalized Children With Respiratory Tract Infections: A 10-Year-Long Study From NorwayLars Høsøien Skanke, Hilde Lysvand, Inger Heimdal, et al.
Frontiers in Pediatrics|May 6, 2026
Clinical manifestations in children with parechovirus A and respiratory tract infectionLars Høsøien Skanke, Inger Heimdal, Hilde Lysvand, et al.
Viruses|September 28, 2021
Nafamostat-Interferon-α Combination Suppresses SARS-CoV-2 Infection In Vitro and In Vivo by Cooperatively Targeting Host TMPRSS2Aleksandr Ianevski, Rouan Yao, Hilde Lysvand, et al.
Plos One|July 29, 2022
The Streptococcus agalactiae R3 surface protein is encoded by sar5Adelle Basson, Camilla Olaisen, Linn-Karina Selvik, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 22, 2020
Discovery and development of safe-in-man broad-spectrum antiviral agentsPetter I Andersen, Aleksandr Ianevski, Hilde Lysvand, et al.
Antiviral Research|February 28, 2024
The combination of pleconaril, rupintrivir, and remdesivir efficiently inhibits enterovirus infections in vitro, delaying the development of drug-resistant virus variantsAleksandr Ianevski, Irene Trøen Frøysa, Hilde Lysvand, et al.
NAR Molecular Medicine|November 19, 2025
JAK inhibitors remove innate immune barriers facilitating viral propagationErlend Ravlo, Aleksandr Ianevski, Marius Nårstad Skipperstøen, et al.
Viruses|June 18, 2020
Potential Antiviral Options against SARS-CoV-2 InfectionAleksandr Ianevski, Rouan Yao, Mona Høysæter Fenstad, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 18, 2023
Boosted production of antibodies that neutralized different SARS-CoV-2 variants in a COVID-19 convalescent following messenger RNA vaccination - a case studyErlend Ravlo, Aleksandr Ianevski, Eirin Starheim, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Viruses|August 28, 2021
Active Components of Commonly Prescribed Medicines Affect Influenza A Virus-Host Cell Interaction: A Pilot StudyAleksandr Ianevski, Rouan Yao, Eva Zusinaite, et al.
Journal of the Pediatric Infectious Diseases Society|April 26, 2021
Parechovirus A in Hospitalized Children With Respiratory Tract Infections: A 10-Year-Long Study From NorwayLars Høsøien Skanke, Hilde Lysvand, Inger Heimdal, et al.
Frontiers in Pediatrics|May 6, 2026
Clinical manifestations in children with parechovirus A and respiratory tract infectionLars Høsøien Skanke, Inger Heimdal, Hilde Lysvand, et al.
Viruses|September 28, 2021
Nafamostat-Interferon-α Combination Suppresses SARS-CoV-2 Infection In Vitro and In Vivo by Cooperatively Targeting Host TMPRSS2Aleksandr Ianevski, Rouan Yao, Hilde Lysvand, et al.
Plos One|July 29, 2022
The Streptococcus agalactiae R3 surface protein is encoded by sar5Adelle Basson, Camilla Olaisen, Linn-Karina Selvik, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 22, 2020
Discovery and development of safe-in-man broad-spectrum antiviral agentsPetter I Andersen, Aleksandr Ianevski, Hilde Lysvand, et al.
Antiviral Research|February 28, 2024
The combination of pleconaril, rupintrivir, and remdesivir efficiently inhibits enterovirus infections in vitro, delaying the development of drug-resistant virus variantsAleksandr Ianevski, Irene Trøen Frøysa, Hilde Lysvand, et al.
NAR Molecular Medicine|November 19, 2025
JAK inhibitors remove innate immune barriers facilitating viral propagationErlend Ravlo, Aleksandr Ianevski, Marius Nårstad Skipperstøen, et al.
Viruses|June 18, 2020
Potential Antiviral Options against SARS-CoV-2 InfectionAleksandr Ianevski, Rouan Yao, Mona Høysæter Fenstad, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 18, 2023
Boosted production of antibodies that neutralized different SARS-CoV-2 variants in a COVID-19 convalescent following messenger RNA vaccination - a case studyErlend Ravlo, Aleksandr Ianevski, Eirin Starheim, et al.
Pageof 3